L
Laurence Collette
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 281
Citations - 37642
Laurence Collette is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 78, co-authored 276 publications receiving 33811 citations. Previous affiliations of Laurence Collette include VU University Amsterdam & Université catholique de Louvain.
Papers
More filters
Journal ArticleDOI
International experts’ panel for the development of guidelines for the definition of time to event endpoints in clinical trials (DATECAN project): Results for pancreatic cancer.
Franck Bonnetain,Adélaïde Doussau,Simone Mathoulin-Pélissier,Bert A. Bonsing,Bengt Glimelius,Karin Haustermans,Thierry Conroy,Jean-Luc Van Laethem,Roberto Labianca,Teresa Macarulla,Murielle Mauer,Manfred P. Lutz,Josep Tabernero,Aimery de Gramont,Pascal Hammel,Daniela E. Aust,Michel Ducreux,Julien Taieb,John P. Neoptolemos,Laurence Collette +19 more
TL;DR: The DATECAN project aimed at obtaining a formal consensus recommendation for defining survival endpoints for randomized clinical trials (RCTs) in the following cancer sites: pancreas, sarcoma/GISTs, breast, colorectal, gastric/œsophagus, head and neck, kidney-bladder.
Book ChapterDOI
How to Interpret Numeric Results in Publications
TL;DR: This chapter will use published reports comparing therapeutic interventions against prostate cancer as examples because modern clinical trials are becoming increasingly complex and therefore more difficult to appraise for the non-statistically trained reader.
Journal ArticleDOI
50 years of the EORTC and the central role of the EORTC Headquarters
Denis Lacombe,John Bean,Jan Bogaerts,Andrew Bottomley,Laurence Collette,Caroline Gilotay,Ann Marinus,Sandrine Marreaud,Pascal Ruyskart,Richard Sylvester,Françoise Meunier +10 more
TL;DR: EORTC Headquarters, armed with a competent and dedicated staff, continues to advance the state of cancer clinical research and implement the appropriate infrastructures to support the conduct of the next generation of cancerclinical trials.
Journal ArticleDOI
4002 ORAL Six months versus three years concomitant and adjuvant hormonal treatment with external beam irradiation for locally advanced prostate cancer: Results of the EORTC randomized Phase III trial 22961
M. Bolla,G. van Tienhoven,T.M. De Reijke,F Van den Bergh,Jorg R. Oddens,P.M. Poortmans,E. Gez,P. Kil,Elena Musat,Laurence Collette +9 more
Journal ArticleDOI
EORTC1527/JCOG1609INT: Diffusion-weighted MRI (DW-MRI) assessment of liver metastasis to improve surgical planning (DREAM).
Kozo Kataoka,Carmela Caballero,Laurence Collette,Kenichi Nakamura,Yoji Kishi,Patrick Starlinger,Hiroaki Onaya,Takeshi Suto,Michel Ducreux,Yasuhiro Shimada,Sabine Tejpar,Laura Rubbia-Brandt,Gina Brown,Manabu Shiozawa,Serge Evrard +14 more
TL;DR: This data indicates that in patients with initially unresectable colorectal liver metastases with good clinical response to chemotherapy, the presence of disappearing liver metastasies diagestion after second-line chemotherapy is a major concern.